OGT and breast cancer: We identified downregulated CARs in vicinity or overlapping the oncogenes IGF1R, MYLK [77], the breast cancer drug target OGT (O-GlcNAc transferase) [78], and the breast cancer-related cyclin CCNL1 [79].